Murli Krishna Pharma Private Ltd. is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharmaceutical products.

Murli Krishna Pharma Private Ltd. was established by Ms. Satya Vadlamani & Dr. Vijay K. Shastri in early 2004 located in India. Driven by the vision to provide the best possible, range of international quality products at competitive prices through integration, research, innovation, technology & development.

Our plant is approved for manufacturing by European Union & for GMP Compliance by the WHO; Murli Krishna Pharma is equipped to undertake formulation development projects on oral NDDS. And the R&D facility is recently approved by DSIRT.

We have a world class oral solid dosage form manufacturing facility for Pellets, Micro-Pellets and Granules approved by regulatory authorities of developed countries.

With a clientele base comprising of more than 64 leading international companies and a turnover exceeding US$ 6 Million, our performance speaks of our capabilities with a cumulative growth of over 60% from the last 3 Years.

We want to carve out a niche in the field of Novel Drug Delivery System(NDDS) & would like to be known as one of the Leading Global Research Based, Drug Delivery Companies, with an expertise in novel drug delivery systems, constantly strive towards building and strengthening upon our intellectual property.

Today, Murli Krishna Pharma is dedicated to achieving the highest levels of quality in everything we do to measure up to the high standard set by the customer, local & overseas customers, every time. We deliver the products as per the set schedules with excellent quality at a very competitive price. With this dedication towards quality, we are able to provide world class products. Our strength lies in our ability to provide a tailored solution to fulfil the specific needs of its customers in question.

Our current activities include manufacturing of pre-finished formulations i.e. pellets using Aqueous Based technology and avoiding use of Solvents completely. We have 3 potential IPRs. We develop platform technology and implement the same.

MKPPL is managed by an experienced Board of Directors, who are assisted by a team of dedicated and qualified professionals drawn from various disciplines.

We are thankful to all our customers, agents, employees and well-wishers for their continuous support to convert our ideas into technology and technologies to success and profit.

We welcome customers from worldwide to start a promising business relationship with us!